PRSC vs. LH, DGX, DVA, CHE, CRVL, AMED, MD, AMN, CCRN, and PAL
Should you be buying Providence Service stock or one of its competitors? The main competitors of Providence Service include Laboratory Co. of America (LH), Quest Diagnostics (DGX), DaVita (DVA), Chemed (CHE), CorVel (CRVL), Amedisys (AMED), Pediatrix Medical Group (MD), AMN Healthcare Services (AMN), Cross Country Healthcare (CCRN), and Proficient Auto Logistics (PAL).
Providence Service vs.
Laboratory Co. of America (NYSE:LH) and Providence Service (NASDAQ:PRSC) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, community ranking, profitability, valuation, media sentiment, analyst recommendations, earnings, risk and institutional ownership.
95.9% of Laboratory Co. of America shares are owned by institutional investors. 0.9% of Laboratory Co. of America shares are owned by company insiders. Comparatively, 7.5% of Providence Service shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
In the previous week, Laboratory Co. of America had 9 more articles in the media than Providence Service. MarketBeat recorded 9 mentions for Laboratory Co. of America and 0 mentions for Providence Service. Laboratory Co. of America's average media sentiment score of 1.41 beat Providence Service's score of 0.00 indicating that Laboratory Co. of America is being referred to more favorably in the media.
Laboratory Co. of America has a net margin of 3.43% compared to Providence Service's net margin of 0.23%. Providence Service's return on equity of 17.59% beat Laboratory Co. of America's return on equity.
Laboratory Co. of America presently has a consensus target price of $260.54, indicating a potential upside of 6.61%. Given Laboratory Co. of America's stronger consensus rating and higher probable upside, research analysts plainly believe Laboratory Co. of America is more favorable than Providence Service.
Laboratory Co. of America has a beta of 1.06, indicating that its stock price is 6% more volatile than the S&P 500. Comparatively, Providence Service has a beta of 0.84, indicating that its stock price is 16% less volatile than the S&P 500.
Laboratory Co. of America received 343 more outperform votes than Providence Service when rated by MarketBeat users. However, 65.71% of users gave Providence Service an outperform vote while only 64.08% of users gave Laboratory Co. of America an outperform vote.
Laboratory Co. of America has higher revenue and earnings than Providence Service. Providence Service is trading at a lower price-to-earnings ratio than Laboratory Co. of America, indicating that it is currently the more affordable of the two stocks.
Summary
Laboratory Co. of America beats Providence Service on 15 of the 19 factors compared between the two stocks.
Get Providence Service News Delivered to You Automatically
Sign up to receive the latest news and ratings for PRSC and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Providence Service Competitors List
Related Companies and Tools
This page (NASDAQ:PRSC) was last updated on 1/22/2025 by MarketBeat.com Staff